The metabolic syndrome and its components as prognostic factors in metastatic colorectal cancer
- 30 January 2019
- journal article
- research article
- Published by Springer Nature in Indian Journal of Gastroenterology
- Vol. 38 (1) , 15-22
Abstract
Components of the metabolic syndrome (MetS) are involved in colorectal cancer development and the incidence of the disease is higher in obese and diabetic patients. Nevertheless, the value of these diseases or the MetS as a whole as prognostic markers once colorectal cancer is diagnosed is controversial.Keywords
Funding Information
- Sault ste marie academic medical association
This publication has 18 references indexed in Scilit:
- Body Mass Index Is Prognostic in Metastatic Colorectal Cancer: Pooled Analysis of Patients From First-Line Clinical Trials in the ARCAD DatabaseJournal of Clinical Oncology, 2016
- Differential impact of obesity and diabetes mellitus on survival after liver resection for colorectal cancer metastasesJournal of Surgical Research, 2015
- The Insulin/IGF System in Colorectal Cancer Development and Resistance to TherapyFrontiers in Oncology, 2015
- Joint prognostic effect of obesity and chronic systemic inflammation in patients with metastatic colorectal cancerCancer, 2015
- Diabetes Mellitus and Colorectal Cancer PrognosisDiseases of the Colon & Rectum, 2013
- Prognostic factors for 60-day mortality in first-line treatment of metastatic colorectal cancer (mCRC): individual patient analysis of four randomised, controlled trials by the AIO colorectal cancer study groupAnnals of Oncology, 2013
- The Association Between Metabolic Syndrome and Colorectal NeoplasmJournal of Clinical Gastroenterology, 2013
- Obesity Is an Independent Prognostic Variable in Colon Cancer SurvivorsClinical Cancer Research, 2010
- Obesity and Risk of Colorectal Cancer: A Meta-analysis of 31 Studies with 70,000 EventsCancer Epidemiology, Biomarkers & Prevention, 2007
- Pathogenesis of colorectal carcinoma and therapeutic implications: the roles of the ubiquitin–proteasome system and Cox‐2Journal of Cellular and Molecular Medicine, 2007